$NHI
NATIONAL HEALTH INVESTORS INC Stock $nhi

$nhi Overview Financials Valuation SEC Filings Company Website

2015 Q2 Form 10-Q Financial Statement

#000087786015000064 Filed on August 05, 2015

Income Statement

Concept	2015 Q2	2014 Q2
Revenue	$56.31M	$44.16M
YoY Change	27.52%	63.02%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin	$2.690M	$2.270M
YoY Change	18.5%	-16.24%
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$13.00M	$9.600M
YoY Change	35.46%	108.7%
% of Gross Profit
Operating Expenses	$24.61M	$18.64M
YoY Change	32.04%	114.29%
Operating Profit		$25.58M
YoY Change		38.43%
Interest Expense	$9.287M	$6.829M
YoY Change	35.99%	327.61%
% of Operating Profit		26.7%
Other Income/Expense, Net
YoY Change
Pretax Income	$31.71M	$25.53M
YoY Change	24.22%	38.68%
Income Tax		$0.00
% Of Pretax Income		0.0%
Net Earnings	$31.18M	$25.29M
YoY Change	23.28%	26.97%
Net Earnings / Revenue	55.37%	57.28%
Basic Earnings Per Share	$0.83	$0.77
Diluted Earnings Per Share	$0.83	$0.76
COMMON SHARES
Basic Shares Outstanding	37.57M shares	33.05M shares
Diluted Shares Outstanding	37.61M shares	33.09M shares

Balance Sheet

Concept	2015 Q2	2014 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments	$17.96M	$21.15M
YoY Change	-15.09%	-58.27%
Cash & Equivalents	$3.293M	$7.157M
Short-Term Investments	$14.66M	$13.99M
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables	$2.907M	$1.519M
Other Receivables	$47.50M	$27.20M
Total Short-Term Assets	$53.70M	$35.90M
YoY Change	49.58%	-36.23%
LONG-TERM ASSETS
Property, Plant & Equipment	$1.751B	$1.290B
YoY Change	35.77%	84.49%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments	$8.911M	$9.704M
YoY Change	-8.17%	4.78%
Other Assets	$34.20M	$23.60M
YoY Change	44.92%	353.85%
Total Long-Term Assets	$1.959B	$1.447B
YoY Change	35.37%	74.17%
TOTAL ASSETS
Total Short-Term Assets	$53.70M	$35.90M
Total Long-Term Assets	$1.959B	$1.447B
Total Assets	$2.013B	$1.483B
YoY Change	35.71%	67.16%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$14.40M	$11.10M
YoY Change	29.73%	184.62%
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$67.60M	$59.30M
YoY Change	14.0%	143.03%
LONG-TERM LIABILITIES
Long-Term Debt	$893.0M	$638.0M
YoY Change	39.97%	64.94%
Other Long-Term Liabilities	$5.600M	$5.400M
YoY Change	3.7%	-23.94%
Total Long-Term Liabilities	$898.6M	$643.4M
YoY Change	39.66%	63.34%
TOTAL LIABILITIES
Total Short-Term Liabilities	$67.60M	$59.30M
Total Long-Term Liabilities	$898.6M	$643.4M
Total Liabilities	$966.3M	$702.7M
YoY Change	37.51%	68.02%
SHAREHOLDERS EQUITY
Retained Earnings
YoY Change
Common Stock	$1.036B	$763.0M
YoY Change	35.73%	62.03%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$1.037B	$770.0M
YoY Change
Total Liabilities & Shareholders Equity	$2.013B	$1.483B
YoY Change	35.71%	67.16%

Cashflow Statement

Concept	2015 Q2	2014 Q2
OPERATING ACTIVITIES
Net Income	$31.18M	$25.29M
YoY Change	23.28%	26.97%
Depreciation, Depletion And Amortization	$13.00M	$9.600M
YoY Change	35.46%	108.7%
Cash From Operating Activities	$41.40M	$32.70M
YoY Change	26.61%	35.68%
INVESTING ACTIVITIES
Capital Expenditures	-$100.0K	-$13.80M
YoY Change	-99.28%	-83.11%
Acquisitions
YoY Change
Other Investing Activities	-$2.400M	-$800.0K
YoY Change	200.0%	-113.56%
Cash From Investing Activities	-$2.400M	-$14.60M
YoY Change	-83.56%	-80.74%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-39.90M	-17.20M
YoY Change	131.98%	-120.95%
NET CHANGE
Cash From Operating Activities	41.40M	32.70M
Cash From Investing Activities	-2.400M	-14.60M
Cash From Financing Activities	-39.90M	-17.20M
Net Change In Cash	-900.0K	900.0K
YoY Change	-200.0%	-97.04%
FREE CASH FLOW
Cash From Operating Activities	$41.40M	$32.70M
Capital Expenditures	-$100.0K	-$13.80M
Free Cash Flow	$41.50M	$46.50M
YoY Change	-10.75%	-56.05%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	nhi	Cash Paid In Settlement Of Contingent Purchase Consideration Liability CashPaidInSettlementOfContingentPurchaseConsiderationLiability	1600000	USD
	nhi	Cash Paid In Settlement Of Contingent Purchase Consideration Liability CashPaidInSettlementOfContingentPurchaseConsiderationLiability	0	USD
CY2015Q2	nhi	Closing Price Of Lt Cs Common Stock ClosingPriceOfLTCsCommonStock	41.60
	dei	Amendment Flag AmendmentFlag	false
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q2
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2015
	dei	Document Period End Date DocumentPeriodEndDate	2015-06-30
	dei	Document Type DocumentType	10-Q
	dei	Entity Central Index Key EntityCentralIndexKey	0000877860
CY2015Q3	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	37566221	shares
	dei	Entity Filer Category EntityFilerCategory	Large Accelerated Filer
	dei	Entity Registrant Name EntityRegistrantName	NATIONAL HEALTH INVESTORS INC
CY2014Q2	nhi	Business Acquisition Pro Forma Netincome Available To Common Stockholders BusinessAcquisitionProFormaNetincomeAvailableToCommonStockholders	29865000	USD
	nhi	Business Acquisition Pro Forma Netincome Available To Common Stockholders BusinessAcquisitionProFormaNetincomeAvailableToCommonStockholders	57994000	USD
	nhi	Convertible Debt Instrument Conversion Ratio Principal Amount Basis ConvertibleDebtInstrumentConversionRatioPrincipalAmountBasis	1000	USD
CY2015Q2	nhi	Credit Facility Current Revolving Borrowing Capacity CreditFacilityCurrentRevolvingBorrowingCapacity	550000000	USD
CY2015Q2	nhi	Credit Facility Expansion Amount CreditFacilityExpansionAmount	250000000	USD
CY2015Q2	nhi	Debt Instrument Variable Interest Rate Reference Rate Basis Points DebtInstrumentVariableInterestRateReferenceRateBasisPoints	19
CY2014Q2	nhi	Depreciation Continuing Operations DepreciationContinuingOperations	9540000	USD
	nhi	Depreciation Continuing Operations DepreciationContinuingOperations	18777000	USD
CY2015Q2	nhi	Depreciation Continuing Operations DepreciationContinuingOperations	13004000	USD
	nhi	Depreciation Continuing Operations DepreciationContinuingOperations	26017000	USD
	nhi	Equity Issuance Costs EquityIssuanceCosts	0	USD
	nhi	Equity Issuance Costs EquityIssuanceCosts	-275000	USD
CY2014Q2	nhi	Franchise Excise And Other Taxes FranchiseExciseAndOtherTaxes	406000	USD
	nhi	Franchise Excise And Other Taxes FranchiseExciseAndOtherTaxes	712000	USD
CY2015Q2	nhi	Franchise Excise And Other Taxes FranchiseExciseAndOtherTaxes	104000	USD
	nhi	Franchise Excise And Other Taxes FranchiseExciseAndOtherTaxes	238000	USD
	nhi	Settlement Of Mortgage Note By Real Estate Acquisition SettlementOfMortgageNoteByRealEstateAcquisition	0	USD
	nhi	Settlement Of Mortgage Note By Real Estate Acquisition SettlementOfMortgageNoteByRealEstateAcquisition	255000	USD
	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Earnings FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings	0	USD
	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Earnings FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings	0	USD
CY2014Q4	us-gaap	Accounts Payable And Accrued Liabilities Current And Noncurrent AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent	15718000	USD
CY2015Q2	us-gaap	Accounts Payable And Accrued Liabilities Current And Noncurrent AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent	14432000	USD
CY2014Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	3818000	USD
CY2015Q2	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	2907000	USD
CY2015Q2	nhi	Investment In Cumulative Preferred Stock InvestmentInCumulativePreferredStock	2000000	shares
CY2015Q1	nhi	Lease Extension Periodin Years LeaseExtensionPeriodinYears	P10Y0M0D
CY2014Q2	nhi	Loanand Lease Lossesand Recoveries Net LoanandLeaseLossesandRecoveriesNet	0	USD
	nhi	Loanand Lease Lossesand Recoveries Net LoanandLeaseLossesandRecoveriesNet	0	USD
CY2015Q2	nhi	Loanand Lease Lossesand Recoveries Net LoanandLeaseLossesandRecoveriesNet	-491000	USD
	nhi	Loanand Lease Lossesand Recoveries Net LoanandLeaseLossesandRecoveriesNet	-491000	USD
CY2015Q2	nhi	Nonemployeedirectorannualstockgrants Nonemployeedirectorannualstockgrants	20000	shares
	nhi	Nonemployeedirectorannualstockgrants Nonemployeedirectorannualstockgrants	15000	shares
CY2015Q2	nhi	Nonportfolio Assets Original Cost NonportfolioAssetsOriginalCost	910000	USD
CY2015Q2	nhi	Nonvoting Convertible Preferred Stock NonvotingConvertiblePreferredStock	2000000	shares
CY2015Q2	nhi	Number Of Health Care Properties Related To Mortgage Notes Receivables NumberOfHealthCarePropertiesRelatedToMortgageNotesReceivables	9	properties
CY2015Q2	nhi	Number Of Lessees NumberOfLessees	24
CY2015Q2	nhi	Original Cost Of Cost Method Investments OriginalCostOfCostMethodInvestments	38132000	USD
CY2015Q2	nhi	Real Estate Investment Property Portfolio Assets RealEstateInvestmentPropertyPortfolioAssets	1982683000	USD
CY2014Q4	nhi	Real Estate Purchase Liabilities RealEstatePurchaseLiabilities	3000000	USD
CY2015Q2	nhi	Real Estate Purchase Liabilities RealEstatePurchaseLiabilities	3000000	USD
CY2014Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	212300000	USD
CY2015Q2	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	233202000	USD
CY2014Q4	us-gaap	Accumulated Distributions In Excess Of Net Income AccumulatedDistributionsInExcessOfNetIncome	569000	USD
CY2015Q2	us-gaap	Accumulated Distributions In Excess Of Net Income AccumulatedDistributionsInExcessOfNetIncome	3566000	USD
CY2014Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	6223000	USD
CY2015Q2	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	4555000	USD
CY2014Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	1033896000	USD
CY2015Q2	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	1035318000	USD
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	1573000	USD
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	1697000	USD
CY2015Q2	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	0	USD
CY2014Q2	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	739000	USD
	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	1081000	USD
CY2015Q2	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	860000	USD
	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	1680000	USD
	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	1081000	USD
	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	1709000	USD
CY2014Q2	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	31575	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	31936	shares
CY2015Q2	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	51643	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	22401	shares
CY2014Q4	us-gaap	Assets Assets	1982960000	USD
CY2015Q2	us-gaap	Assets Assets	2012820000	USD
CY2014Q4	us-gaap	Available For Sale Securities Accumulated Gross Unrealized Gain Loss Before Tax AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainLossBeforeTax	11415000	USD
CY2015Q2	us-gaap	Available For Sale Securities Accumulated Gross Unrealized Gain Loss Before Tax AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainLossBeforeTax	10576000	USD
CY2014Q4	us-gaap	Available For Sale Securities Amortized Cost AvailableForSaleSecuritiesAmortizedCost	4088000	USD
CY2015Q2	us-gaap	Available For Sale Securities Amortized Cost AvailableForSaleSecuritiesAmortizedCost	4088000	USD
CY2014Q4	us-gaap	Available For Sale Securities Equity Securities AvailableForSaleSecuritiesEquitySecurities	15503000	USD
CY2015Q2	us-gaap	Available For Sale Securities Equity Securities AvailableForSaleSecuritiesEquitySecurities	14664000	USD
CY2014Q2	us-gaap	Business Acquisition Pro Forma Earnings Per Share Basic BusinessAcquisitionProFormaEarningsPerShareBasic	0.80
	us-gaap	Business Acquisition Pro Forma Earnings Per Share Basic BusinessAcquisitionProFormaEarningsPerShareBasic	1.55
CY2014Q2	us-gaap	Business Acquisition Pro Forma Earnings Per Share Diluted BusinessAcquisitionProFormaEarningsPerShareDiluted	0.80
	us-gaap	Business Acquisition Pro Forma Earnings Per Share Diluted BusinessAcquisitionProFormaEarningsPerShareDiluted	1.55
CY2014Q2	us-gaap	Business Acquisitions Pro Forma Net Income Loss BusinessAcquisitionsProFormaNetIncomeLoss	30148000	USD
	us-gaap	Business Acquisitions Pro Forma Net Income Loss BusinessAcquisitionsProFormaNetIncomeLoss	58600000	USD
CY2014Q2	us-gaap	Business Acquisitions Pro Forma Revenue BusinessAcquisitionsProFormaRevenue	54015000	USD
	us-gaap	Business Acquisitions Pro Forma Revenue BusinessAcquisitionsProFormaRevenue	107007000	USD
CY2013Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	11312000	USD
CY2014Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	7157000	USD
CY2014Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	3287000	USD
CY2015Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	3293000	USD
CY2015Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	3293000	USD
	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	-4155000	USD
	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	6000	USD
CY2014Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2015Q2	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2014Q2	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.770
	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	1.54
CY2015Q2	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.85
	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	1.70
CY2014Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2015Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2014Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	60000000	shares
CY2015Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	60000000	shares
CY2014Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	37485902	shares
CY2015Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	37566221	shares
CY2014Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	37485902	shares
CY2015Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	37566221	shares
CY2014Q4	us-gaap	Common Stock Value CommonStockValue	375000	USD
CY2015Q2	us-gaap	Common Stock Value CommonStockValue	376000	USD
CY2014Q2	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	22578000	USD
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	45314000	USD
CY2015Q2	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	31917000	USD
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	59198000	USD
CY2014Q2	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	283000	USD
	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	606000	USD
CY2015Q2	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	355000	USD
	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	685000	USD
CY2014Q2	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	22861000	USD
	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	45920000	USD
CY2015Q2	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	32272000	USD
	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	59883000	USD
CY2014Q4	us-gaap	Construction In Progress Gross ConstructionInProgressGross	6428000	USD
CY2014Q4	us-gaap	Deferred Revenue DeferredRevenue	1071000	USD
CY2015Q2	us-gaap	Construction In Progress Gross ConstructionInProgressGross	10219000	USD
CY2014Q1	us-gaap	Convertible Debt ConvertibleDebt	192238000	USD
CY2014Q4	us-gaap	Convertible Debt ConvertibleDebt	193037000	USD
CY2015Q2	us-gaap	Convertible Debt ConvertibleDebt	193582000	USD
CY2014Q4	us-gaap	Cost Method Investments CostMethodInvestments	38132000	USD
CY2015Q2	us-gaap	Cost Method Investments CostMethodInvestments	38132000	USD
CY2015Q2	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	901068000	USD
CY2015Q1	us-gaap	Debt Instrument Convertible Carrying Amount Of The Equity Component DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent	7762000	USD
CY2015Q2	us-gaap	Debt Instrument Convertible Conversion Price1 DebtInstrumentConvertibleConversionPrice1	71.81
	us-gaap	Debt Instrument Convertible Conversion Ratio1 DebtInstrumentConvertibleConversionRatio1	13.926
	us-gaap	Debt Instrument Convertible Number Of Equity Instruments DebtInstrumentConvertibleNumberOfEquityInstruments	2785200	shares
CY2015Q1	us-gaap	Debt Instrument Interest Rate Effective Percentage DebtInstrumentInterestRateEffectivePercentage	0.039
CY2015Q2	us-gaap	Debt Instrument Unamortized Discount DebtInstrumentUnamortizedDiscount	8036000	USD
CY2014Q4	us-gaap	Debt Longterm And Shortterm Combined Amount DebtLongtermAndShorttermCombinedAmount	862726000	USD
CY2015Q2	us-gaap	Debt Longterm And Shortterm Combined Amount DebtLongtermAndShorttermCombinedAmount	893032000	USD
CY2014Q4	us-gaap	Deferred Costs And Other Assets DeferredCostsAndOtherAssets	50705000	USD
CY2015Q2	us-gaap	Deferred Costs And Other Assets DeferredCostsAndOtherAssets	50245000	USD
CY2014Q4	us-gaap	Deferred Rent Receivables Net DeferredRentReceivablesNet	35154000	USD
CY2015Q2	us-gaap	Deferred Rent Receivables Net DeferredRentReceivablesNet	47462000	USD
CY2015Q2	us-gaap	Deferred Revenue DeferredRevenue	2643000	USD
	us-gaap	Depreciation Nonproduction DepreciationNonproduction	18777000	USD
	us-gaap	Depreciation Nonproduction DepreciationNonproduction	26017000	USD
	us-gaap	Dividends Common Stock Cash DividendsCommonStockCash	63863000	USD
CY2014Q4	us-gaap	Dividends Payable Current And Noncurrent DividendsPayableCurrentAndNoncurrent	28864000	USD
CY2015Q2	us-gaap	Dividends Payable Current And Noncurrent DividendsPayableCurrentAndNoncurrent	31931000	USD
CY2014Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.77
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.48
CY2015Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.83
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.62
CY2014Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.76
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.48
CY2015Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.83
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.62
CY2015Q2	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized	898000	USD
CY2015Q2	us-gaap	Equity Method Investment Difference Between Carrying Amount And Underlying Equity EquityMethodInvestmentDifferenceBetweenCarryingAmountAndUnderlyingEquity	8986000	USD
CY2014Q4	us-gaap	Equity Method Investments EquityMethodInvestments	9424000	USD
CY2015Q2	us-gaap	Equity Method Investments EquityMethodInvestments	8911000	USD
CY2014Q4	us-gaap	Escrow Deposit EscrowDeposit	4324000	USD
CY2015Q2	us-gaap	Escrow Deposit EscrowDeposit	4475000	USD
	us-gaap	Escrow Deposit Disbursements Related To Property Acquisition1 EscrowDepositDisbursementsRelatedToPropertyAcquisition1	23813000	USD
	us-gaap	Escrow Deposit Disbursements Related To Property Acquisition1 EscrowDepositDisbursementsRelatedToPropertyAcquisition1	0	USD
	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Gain Loss Included In Earnings1 FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1	0	USD
	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Gain Loss Included In Earnings1 FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1	0	USD
	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Transfers Into Level3 FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3	0	USD
	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Transfers Into Level3 FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3	0	USD
	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Purchases Sales Issuances Settlements FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchasesSalesIssuancesSettlements	-1400000	USD
	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Purchases Sales Issuances Settlements FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchasesSalesIssuancesSettlements	0	USD
CY2014Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1850000	USD
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	4785000	USD
CY2015Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	2514000	USD
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	6358000	USD
CY2014Q2	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	25294000	USD
CY2015Q2	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	31182000	USD
CY2014Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	25525000	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	49224000	USD
CY2015Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	31820000	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	62064000	USD
CY2014Q2	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	0.77
CY2015Q2	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	0.83
CY2014Q2	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	0.76
CY2015Q2	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	0.83
CY2014Q2	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	52000	USD
	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	210000	USD
CY2015Q2	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-283000	USD
	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-513000	USD
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	177000	USD
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-1004000	USD
	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	-2486000	USD
	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	1572000	USD
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	381000	USD
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-740000	USD
	us-gaap	Incremental Common Shares Attributable To Conversion Of Debt Securities IncrementalCommonSharesAttributableToConversionOfDebtSecurities	0	shares
	us-gaap	Incremental Common Shares Attributable To Conversion Of Debt Securities IncrementalCommonSharesAttributableToConversionOfDebtSecurities	9471	shares
CY2014Q2	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	34533	shares
	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	34175	shares
CY2015Q2	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	40896	shares
	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	54577	shares
CY2014Q2	us-gaap	Interest Costs Capitalized InterestCostsCapitalized	-88000	USD
	us-gaap	Interest Costs Capitalized InterestCostsCapitalized	-211000	USD
CY2015Q2	us-gaap	Interest Costs Capitalized InterestCostsCapitalized	-84000	USD
	us-gaap	Interest Costs Capitalized InterestCostsCapitalized	-204000	USD
CY2014Q2	us-gaap	Interest Expense InterestExpense	6829000	USD
	us-gaap	Interest Expense InterestExpense	13715000	USD
CY2015Q2	us-gaap	Interest Expense InterestExpense	9287000	USD
	us-gaap	Interest Expense InterestExpense	17699000	USD
CY2014Q2	us-gaap	Interest Expense Debt Excluding Amortization InterestExpenseDebtExcludingAmortization	6178000	USD
	us-gaap	Interest Expense Debt Excluding Amortization InterestExpenseDebtExcludingAmortization	10700000	USD
CY2015Q2	us-gaap	Interest Expense Debt Excluding Amortization InterestExpenseDebtExcludingAmortization	8511000	USD
	us-gaap	Interest Expense Debt Excluding Amortization InterestExpenseDebtExcludingAmortization	16223000	USD
CY2014Q2	us-gaap	Interest Income Operating InterestIncomeOperating	1748000	USD
	us-gaap	Interest Income Operating InterestIncomeOperating	3504000	USD
CY2015Q2	us-gaap	Interest Income Operating InterestIncomeOperating	2521000	USD
	us-gaap	Interest Income Operating InterestIncomeOperating	4642000	USD
	us-gaap	Interest Paid InterestPaid	8886000	USD
CY2014Q4	us-gaap	Liabilities Liabilities	933027000	USD
CY2015Q2	us-gaap	Liabilities Liabilities	966313000	USD
CY2014Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	1982960000	USD
CY2015Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	2012820000	USD
CY2014Q4	us-gaap	Line Of Credit LineOfCredit	374000000	USD
CY2015Q2	us-gaap	Line Of Credit LineOfCredit	101000000	USD
	us-gaap	Line Of Credit Facility Increase Decrease For Period Net LineOfCreditFacilityIncreaseDecreaseForPeriodNet	51000000	USD
	us-gaap	Interest Paid InterestPaid	13723000	USD
CY2014Q4	us-gaap	Investment Building And Building Improvements InvestmentBuildingAndBuildingImprovements	1854855000	USD
CY2015Q2	us-gaap	Investment Building And Building Improvements InvestmentBuildingAndBuildingImprovements	1843519000	USD
CY2014Q2	us-gaap	Investment Income Net InvestmentIncomeNet	1059000	USD
	us-gaap	Investment Income Net InvestmentIncomeNet	2126000	USD
CY2015Q2	us-gaap	Investment Income Net InvestmentIncomeNet	1122000	USD
	us-gaap	Investment Income Net InvestmentIncomeNet	2257000	USD
CY2014Q4	us-gaap	Land Land	127566000	USD
CY2015Q2	us-gaap	Land Land	130340000	USD
CY2014Q2	us-gaap	Legal Fees LegalFees	10000	USD
	us-gaap	Legal Fees LegalFees	83000	USD
CY2015Q2	us-gaap	Legal Fees LegalFees	75000	USD
	us-gaap	Legal Fees LegalFees	179000	USD
	us-gaap	Lessor Leasing Arrangements Operating Leases Renewal Term LessorLeasingArrangementsOperatingLeasesRenewalTerm	P5Y0M0D
	us-gaap	Line Of Credit Facility Increase Decrease For Period Net LineOfCreditFacilityIncreaseDecreaseForPeriodNet	273000000	USD
CY2015Q2	us-gaap	Line Of Credit Facility Maximum Borrowing Capacity LineOfCreditFacilityMaximumBorrowingCapacity	800000000	USD
	us-gaap	Line Of Credit Facility Unused Capacity Commitment Fee Percentage LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage	40
CY2014Q4	us-gaap	Loans And Leases Receivable Net Reported Amount LoansAndLeasesReceivableNetReportedAmount	63630000	USD
CY2015Q2	us-gaap	Loans And Leases Receivable Net Reported Amount LoansAndLeasesReceivableNetReportedAmount	99681000	USD
CY2015Q2	us-gaap	Long Term Debt Maturities Repayments Of Principal In Next Rolling Twelve Months LongTermDebtMaturitiesRepaymentsOfPrincipalInNextRollingTwelveMonths	755000	USD
CY2015Q2	us-gaap	Long Term Debt Maturities Repayments Of Principal In Rolling After Year Five LongTermDebtMaturitiesRepaymentsOfPrincipalInRollingAfterYearFive	546025000	USD
CY2015Q2	us-gaap	Long Term Debt Maturities Repayments Of Principal In Rolling Year Five LongTermDebtMaturitiesRepaymentsOfPrincipalInRollingYearFive	250864000	USD
CY2015Q2	us-gaap	Long Term Debt Maturities Repayments Of Principal In Rolling Year Four LongTermDebtMaturitiesRepaymentsOfPrincipalInRollingYearFour	101835000	USD
CY2015Q2	us-gaap	Long Term Debt Maturities Repayments Of Principal In Rolling Year Three LongTermDebtMaturitiesRepaymentsOfPrincipalInRollingYearThree	808000	USD
CY2015Q2	us-gaap	Long Term Debt Maturities Repayments Of Principal In Rolling Year Two LongTermDebtMaturitiesRepaymentsOfPrincipalInRollingYearTwo	781000	USD
CY2014Q4	us-gaap	Marketable Securities MarketableSecurities	15503000	USD
CY2015Q2	us-gaap	Marketable Securities MarketableSecurities	14664000	USD
CY2014Q4	us-gaap	Minority Interest MinorityInterest	10008000	USD
CY2015Q2	us-gaap	Minority Interest MinorityInterest	9824000	USD
	us-gaap	Minority Interest Decrease From Distributions To Noncontrolling Interest Holders MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders	869000	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-29141000	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-34527000	USD
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-36634000	USD
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-45463000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	61620000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	79996000	USD
CY2014Q2	us-gaap	Net Income Loss NetIncomeLoss	25294000	USD
	us-gaap	Net Income Loss NetIncomeLoss	48828000	USD
	us-gaap	Payments To Minority Shareholders PaymentsToMinorityShareholders	869000	USD
CY2015Q2	us-gaap	Net Income Loss NetIncomeLoss	31182000	USD
	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	1341000	USD
	us-gaap	Net Income Loss NetIncomeLoss	60866000	USD
CY2014Q2	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	283000	USD
	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	606000	USD
CY2015Q2	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	355000	USD
	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	685000	USD
	us-gaap	Noncash Or Part Noncash Acquisition Value Of Liabilities Assumed1 NoncashOrPartNoncashAcquisitionValueOfLiabilitiesAssumed1	2103000	USD
	us-gaap	Noncash Or Part Noncash Acquisition Value Of Liabilities Assumed1 NoncashOrPartNoncashAcquisitionValueOfLiabilitiesAssumed1	1112000	USD
CY2015Q2	us-gaap	Number Of Real Estate Properties NumberOfRealEstateProperties	174	properties
CY2015Q2	us-gaap	Number Of States In Which Entity Operates NumberOfStatesInWhichEntityOperates	31
CY2014Q2	us-gaap	Operating Expenses OperatingExpenses	18635000	USD
	us-gaap	Operating Expenses OperatingExpenses	38072000	USD
CY2015Q2	us-gaap	Operating Expenses OperatingExpenses	24493000	USD
	us-gaap	Operating Expenses OperatingExpenses	50000000	USD
CY2014Q2	us-gaap	Operating Leases Income Statement Lease Revenue OperatingLeasesIncomeStatementLeaseRevenue	41353000	USD
	us-gaap	Operating Leases Income Statement Lease Revenue OperatingLeasesIncomeStatementLeaseRevenue	81666000	USD
CY2015Q2	us-gaap	Operating Leases Income Statement Lease Revenue OperatingLeasesIncomeStatementLeaseRevenue	52670000	USD
	us-gaap	Operating Leases Income Statement Lease Revenue OperatingLeasesIncomeStatementLeaseRevenue	105165000	USD
CY2014Q2	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-2716000	USD
	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-3514000	USD
CY2015Q2	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	735000	USD
	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-1668000	USD
CY2014Q2	us-gaap	Other Comprehensive Income Loss Reclassification Adjustment From Aoci On Derivatives Net Of Tax OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesNetOfTax	1190000	USD
	us-gaap	Other Comprehensive Income Loss Reclassification Adjustment From Aoci On Derivatives Net Of Tax OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesNetOfTax	1718000	USD
CY2015Q2	us-gaap	Other Comprehensive Income Loss Reclassification Adjustment From Aoci On Derivatives Net Of Tax OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesNetOfTax	1177000	USD
	us-gaap	Other Comprehensive Income Loss Reclassification Adjustment From Aoci On Derivatives Net Of Tax OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesNetOfTax	2134000	USD
CY2014Q2	us-gaap	Other Comprehensive Income Unrealized Gain Loss On Derivatives Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax	-2079000	USD
	us-gaap	Other Comprehensive Income Unrealized Gain Loss On Derivatives Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax	-3137000	USD
CY2015Q2	us-gaap	Other Comprehensive Income Unrealized Gain Loss On Derivatives Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax	3635000	USD
	us-gaap	Other Comprehensive Income Unrealized Gain Loss On Derivatives Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax	1305000	USD
CY2014Q2	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	553000	USD
CY2015Q2	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	-1723000	USD
	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	-839000	USD
	us-gaap	Other Significant Noncash Transaction Value Of Consideration Given1 OtherSignificantNoncashTransactionValueOfConsiderationGiven1	3000000	USD
	us-gaap	Other Significant Noncash Transaction Value Of Consideration Given1 OtherSignificantNoncashTransactionValueOfConsiderationGiven1	0	USD
	us-gaap	Payments For Capital Improvements PaymentsForCapitalImprovements	2076000	USD
	us-gaap	Payments For Capital Improvements PaymentsForCapitalImprovements	1816000	USD
	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	7007000	USD
	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	2305000	USD
	us-gaap	Payments Of Dividends PaymentsOfDividends	49743000	USD
	us-gaap	Payments Of Dividends PaymentsOfDividends	60795000	USD
	us-gaap	Payments To Acquire Mortgage Notes Receivable PaymentsToAcquireMortgageNotesReceivable	1214000	USD
	us-gaap	Payments To Acquire Mortgage Notes Receivable PaymentsToAcquireMortgageNotesReceivable	52580000	USD
	us-gaap	Payments To Acquire Real Estate PaymentsToAcquireRealEstate	29423000	USD
	us-gaap	Payments To Acquire Real Estate PaymentsToAcquireRealEstate	3261000	USD
	us-gaap	Payments To Develop Real Estate Assets PaymentsToDevelopRealEstateAssets	3320000	USD
	us-gaap	Payments To Develop Real Estate Assets PaymentsToDevelopRealEstateAssets	4571000	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	1697000	USD
	us-gaap	Payments To Minority Shareholders PaymentsToMinorityShareholders	865000	USD
	us-gaap	Preferred Stock Dividend Rate Percentage PreferredStockDividendRatePercentage	0.085
CY2015Q2	us-gaap	Preferred Stock Liquidation Preference PreferredStockLiquidationPreference	19.25
	us-gaap	Proceeds From Bank Debt ProceedsFromBankDebt	0	USD
	us-gaap	Proceeds From Bank Debt ProceedsFromBankDebt	225000000	USD
	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	200000000	USD
	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	0	USD
	us-gaap	Proceeds From Issuance Of Secured Debt ProceedsFromIssuanceOfSecuredDebt	130000000	USD
	us-gaap	Proceeds From Issuance Of Secured Debt ProceedsFromIssuanceOfSecuredDebt	78084000	USD
	us-gaap	Proceeds From Recoveries Of Loan Previously Charged Off ProceedsFromRecoveriesOfLoanPreviouslyChargedOff	0	USD
	us-gaap	Proceeds From Recoveries Of Loan Previously Charged Off ProceedsFromRecoveriesOfLoanPreviouslyChargedOff	-491000	USD
	us-gaap	Proceeds From Sale And Collection Of Mortgage Notes Receivable ProceedsFromSaleAndCollectionOfMortgageNotesReceivable	999000	USD
	us-gaap	Proceeds From Sale And Collection Of Mortgage Notes Receivable ProceedsFromSaleAndCollectionOfMortgageNotesReceivable	16765000	USD
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	0	USD
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	1000	USD
CY2014Q2	us-gaap	Profit Loss ProfitLoss	25577000	USD
	us-gaap	Profit Loss ProfitLoss	49434000	USD
CY2015Q2	us-gaap	Profit Loss ProfitLoss	31537000	USD
	us-gaap	Profit Loss ProfitLoss	61551000	USD
CY2014Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	1988849000	USD
CY2015Q2	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	1984078000	USD
CY2014Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1776549000	USD
CY2015Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1750876000	USD
CY2014Q4	us-gaap	Real Estate Heldforsale RealEstateHeldforsale	0	USD
CY2015Q2	us-gaap	Real Estate Heldforsale RealEstateHeldforsale	8467000	USD
	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	250526000	USD
	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	368000	USD
CY2014Q2	us-gaap	Revenues Revenues	44160000	USD
	us-gaap	Revenues Revenues	87296000	USD
CY2015Q2	us-gaap	Revenues Revenues	56313000	USD
	us-gaap	Revenues Revenues	112064000	USD
CY2014Q4	us-gaap	Security Deposit SecurityDeposit	21648000	USD
CY2015Q2	us-gaap	Security Deposit SecurityDeposit	21275000	USD
CY2014Q4	us-gaap	Security Deposit Liability SecurityDepositLiability	21648000	USD
CY2015Q2	us-gaap	Security Deposit Liability SecurityDepositLiability	21275000	USD
CY2014Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	676659	shares
CY2015Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	596664	shares
CY2013Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	516674	shares
CY2014Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	903340	shares
CY2014Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	871671	shares
CY2015Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	870012	shares
	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	1000	USD
CY2014Q2	us-gaap	Stock Option Plan Expense StockOptionPlanExpense	223000	USD
	us-gaap	Stock Option Plan Expense StockOptionPlanExpense	1573000	USD
CY2015Q2	us-gaap	Stock Option Plan Expense StockOptionPlanExpense	233000	USD
	us-gaap	Stock Option Plan Expense StockOptionPlanExpense	1697000	USD
CY2014Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	1049933000	USD
CY2015Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	1046507000	USD
CY2014Q4	us-gaap	Stockholders Equity StockholdersEquity	1039925000	USD
CY2015Q2	us-gaap	Stockholders Equity StockholdersEquity	1036683000	USD
	us-gaap	Straight Line Rent StraightLineRent	8490000	USD
	us-gaap	Straight Line Rent StraightLineRent	12308000	USD
CY2014Q4	us-gaap	Unamortized Debt Issuance Expense UnamortizedDebtIssuanceExpense	11491000	USD
CY2015Q2	us-gaap	Unamortized Debt Issuance Expense UnamortizedDebtIssuanceExpense	12677000	USD
CY2014Q4	us-gaap	Unsecured Debt UnsecuredDebt	250000000	USD
CY2015Q2	us-gaap	Unsecured Debt UnsecuredDebt	250000000	USD
CY2014Q2	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	33052750	shares
	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	33052083	shares
CY2015Q2	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	37566221	shares
	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	37562144	shares
CY2014Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	33087283	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	33086258	shares
CY2015Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	37607117	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	37626192	shares
CY2014Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	33052750	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	33052083	shares
CY2015Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	37566221	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	37562144	shares
CY2014Q2	us-gaap	Write Off Of Deferred Debt Issuance Cost WriteOffOfDeferredDebtIssuanceCost	0	USD
	us-gaap	Write Off Of Deferred Debt Issuance Cost WriteOffOfDeferredDebtIssuanceCost	2145000	USD
CY2015Q2	us-gaap	Write Off Of Deferred Debt Issuance Cost WriteOffOfDeferredDebtIssuanceCost	0	USD
	us-gaap	Write Off Of Deferred Debt Issuance Cost WriteOffOfDeferredDebtIssuanceCost	0	USD
	us-gaap	Use Of Estimates UseOfEstimates	<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:justify;text-indent:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Use of Estimates -</font><font style="font-family:inherit;font-size:10pt;"> The preparation of consolidated financial statements in conformity with accounting principles generally accepted in the U.S. requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the date of the financial statements, and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.</font></div></div>

Files In Submission

Name	View Source	Status
0000877860-15-000064-index-headers.html	Edgar Link	pending
0000877860-15-000064-index.html	Edgar Link	pending
0000877860-15-000064.txt	Edgar Link	pending
0000877860-15-000064-xbrl.zip	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
nhi-20150630.xml	Edgar Link	completed
nhi-20150630.xsd	Edgar Link	pending
nhi-20150630_cal.xml	Edgar Link	unprocessable
nhi-20150630_def.xml	Edgar Link	unprocessable
nhi-20150630_lab.xml	Edgar Link	unprocessable
nhi-20150630_pre.xml	Edgar Link	unprocessable
nhi-6302015x10q.htm	Edgar Link	pending
nhi-6302015x10qex1013rdamd.htm	Edgar Link	pending
nhi-6302015x10qex102pruamd.htm	Edgar Link	pending
nhi-6302015x10qex311.htm	Edgar Link	pending
nhi-6302015x10qex312.htm	Edgar Link	pending
nhi-6302015x10qex32.htm	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$NHI
NATIONAL HEALTH INVESTORS INC Stock $nhi

2015 Q2 Form 10-Q Financial Statement

#000087786015000064 Filed on August 05, 2015

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$NHI NATIONAL HEALTH INVESTORS INC Stock $nhi

2015 Q2 Form 10-Q Financial Statement

#000087786015000064 Filed on August 05, 2015

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$NHI
NATIONAL HEALTH INVESTORS INC Stock $nhi